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Letter to the Editor
An Open Letter to The Hong Kong College of Cardiology Regarding
Electron Beam Computed Tomography (EBT)

Dear Editor,
Ref: "Comment on Electron Beam Computed
Tomography" by Dr. Patrick T H Ko. Letter to the
Editor, J HK Coll Cardiol, Vol 11, 2003.
My experience with Electron Beam Computed
Tomography (EBT) now dates me at over 20 years of
research and clinical practice, initially in cardiac
physiology, but for the past decade in coronary
atherosclerosis, athersoclerosis imaging, and Preventive
Cardiology. Thus, I feel I can speak from some level of
authority as well as considerable experience. The point
in question relates to the use of EBT and coronary
calcium scoring for defining coronary disease in a noninvasive manner. I will admit, like many trained formally
in traditional Cardiology and brought up with the idea
that definition of coronary stenoses severity was our
standard in defining coronary disease, that my initial
efforts in using coronary calcium were directed towards
that end.
Our initial studies from autopsy specimens during
my tenure at the Mayo Clinic defined that coronary
calcium area, by direct histologic comparisons as well
as by EBT, was a valid surrogate to defining in situ
atherosclerotic plaque.1-3 The next step was to then
determine application of the non-invasive EBT calcium
score to defining stenosis severity in patients referred
for clinically indicated invasive coronary angiography.
This is where our initial efforts demonstrated that we
could in fact NOT define coronary stenosis severity
adequate for clinical diagnostic purposes using the EBT
calcium score.4,5 I was initially taken-aback by these
findings and also joined with my cardiology colleagues
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in defining the potential for "false positive" results using
EBT. In fact, however, as I have come to learn, the
results were NOT false, but clearly showed that
coronary calcium in any given site is 100% specific
for coronary atherosclerosis, but NOT specific for
the degree of narrowing. My Mayo Clinic colleagues
and I in fact further investigated this and reported on a
resolution of the problem in a separate necropsy study.6
What we found was that coronary calcium did continue
to define coronary atheromatous plaque, but failed to
define site-by-site stenosis severity due to the
phenomenon of coronary artery remodeling, mentioned
by Dr. Ko in his Editorial. This concept was initially
reported by Dr. Glagov, at the University of Chicago,
where he and his colleagues demonstrated that coronary
plaque may progress by expanding the mural surfaces
and yet not necessarily, until its later stages, result in
luminal narrowing.7
The traditional view from most Cardiologists had
been that a definition of "coronary artery disease" was
a stenosis of significant magnitude, defined as generally
representing a singular or multiple narrowing defined on
a "luminogram" of >50-70%. Over the years, however,
we have subsequently learned that atherosclerosis is
a diffuse disease and that focusing, as a means of
defining "disease", on a stenosis of >50% vastly
underestimates the severity and extent of the
underlying atherosclerosis in a given individual.
Dr. Steven Nissen, Vice-Chair of Cardiology at the
Cleveland Clinic, has perhaps been the best at pointing
out the inadequacies of traditional coronary angiography
by performing simultaneous investigations using
intravascular ultrasound (IVUS). He has demonstrated
that individuals may well have a "normal" coronary
angiogram (i.e. luminogram) and yet have "significant"
atheromatous disease 8 due to "positive coronary
remodeling". Subsequent to these investigations my
colleagues and I compared "apples with apples"
demonstrating that the coronary artery calcium score
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by EBT correlated well with IVUS definition of
atheromatous plaque.9,10
Dr. Ko states in his Editorial that coronary
angiography is "…the diagnostic gold standard…".
Many recent authors would dispute that statement as it
relates to atheromatous plaque, as discussed above,
although it does remain the clinical standard for defining
the site of "significant luminal narrowing" that are targets
for PCI and/or road maps for bypass surgery. His
statement later however that "EBCT (is)…not
specific or accurate in so far as the diagnosis or the
staging of clinically significant coronary disease…"
is frankly and explicitly inaccurate. The goal of EBT
is to define the extent of atherosclerotic plaque and thus
its "accuracy" in defining clinically significant disease
should be better understood in its ability to predict risk
of coronary events or clinically significant outcomes. The
premise (or promise, more appropriately) of EBT is not
to "define significant coronary artery disease", as
implied by Dr. Ko, but to define the extent of coronary
artheromatous plaque. Thus he has mis-stated his claim
when he indicated that "The premise of EBCT is thus
defeated". In fact the "promise" of EBT has been
fortified by collective literature that has added
incrementally to our understanding over the past decade.
Dr. Ko is indeed correct in that the formation of
mural coronary artery calcification, in response to the
inflammatory nature of coronary disease, may well form
to provide a lattice of support in an attempt to render
the plaque stable. However, the pathological literature
shows11 that 80% of the "culprit" lesions in necropsy
studies contain histologic calcium hydroxyapatitie.
However, many stable lesions show the same predilection
underscoring that coronary calcium is neither a unique
marker for stable nor unstable plaque. Although so called
"vulnerable" plaques have been shown to be more
predominantly lipid laden than calcium laden, this does
not limit the value of EBT and calcium scoring in
estimating the overall extent of atherosclerosis plaque
present. In any given individual about 2/3 of plaque is in
fact "scar" and about 1/3 is more predominantly "lipid
laden". Thus EBT cannot be used to define which plaque
is unstable, but can and has been shown to define disease
extent (even compared with the "extent" of angiographic
disease or the extent of thallium perfusion defects12).
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The proof of the above statements must be
founded in the prediction of clinical outcomes using
coronary calcium by EBT as a measure of disease.
Although Dr. Ko quotes one paper suggesting that EBT
provided no incremental value over the sum of ALL
conventional risk factors 13 [of note and lost to most
"crities" is that risk factors also failed to predict events
adequately in the same cohort], subsequent research
(even from that same laboratory) has demonstrated
that the coronary calcium score by EBT provided
prognostic information independent and
incremental to conventional risk factors. 14-17
Angiographic studies over the past 25 years have
demonstrated that the extent of coronary disease is
directly related to prognosis. 18,19 The presence of
moderate amounts of coronary calcium (i.e., EBT scores
exceeding 100) has been shown in several studies to
predict cardiac events in symptomatic 20 and
asymptomatic21 individuals. The relative risk of a cardiac
event in an individual with a moderate to high calcium
score by EBT compared to an individual who has no or
minimal coronary calcium has ranged form a mean of
8.66:122 in a meta-analysis review of EBT to as high as
15:123 over a 2-4 year follow up time period in a more
recent publication. The magnitude of the risk associated
with coronary calcium is underscored when one
considers the relative risks of developing symptomatic
coronary artery disease in younger patients based upon
conventional individual "risk factors" (15 year follow up
Framingham study of initially asymptomatic men) is only
1.9:1 for an elevated Lp(a), 1.8:1 for total cholesterol
>240 mg/dl., 1.8:1 for an HDL <35 mg/dl, 3.6:1 for
cigarette smoking, and 1.2:1 for systolic hypertension.24
The data show that, although EBT cannot define
coronary stenosis severity, it CAN suggest that with
higher scores, or in the presence of symptoms24 that
further examination such as stress testing, EBA
(electron beam non-invasive coronary angiography), or
even formal angiography may be warranted. However,
this determination must be made on a case-by-case basis
and is a clinical decision made by an experienced
practitioner. Outcomes of such subsequent testing are
then used to assist in the patient's care.
The current overall guidelines for EBT test
interpretation can be expressed in several bullet points
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as provided below. These statements, supported by
published literature, still must function only as overall
"guides" for the clinician. However, in my opinion, these
interpretation are in fact being well put forward by
experienced practitioners currently performing EBT
examinations in Hong Kong.
Interpretation and recommendation for EBT heart
scanning and CAC scoring:
• A negative test (i.e. score=0, no detectable coronary
calcium) makes the presence of atherosclerotic
plaque, including unstable or vulnerable plaque, highly
unlikely.
• A negative test (score=0) makes the presence of
significant luminal obstructive disease highly unlikely
(negative predictive power by EBT on the order of
95-99%).
• A negative test is consistent with a low risk (reported
to be <0.5% per year26) of a significant cardiovascular
event [infarction or sudden death] in the next 2-5
years.
• A positive test (i.e. a score >0) confirms the presence
of a coronary atherosclerotic plaque (100%
specificity for fibro-atheromatous plaque).
• The greater the EBT calcium score, the greater the
atherosclerotic burden in men and women,
irrespective of age, and the greater "likelihood" of
more advanced luminal disease.5
• The total (summed) coronary calcium score
correlated best with the total amount of coronary
atherosclerotic plaque, although the true
"atherosclerotic burden" is underestimated and,
without use of contrast (as in an EBA study), "soft"
plaque may not be well appreciated (but data are
advancing to address this issue using non-contrast
EBT 27).
• A high calcium score (an Agatston score >100 or
any score above the 75th percentile for age and sex
as compared to published EBT databases) is
consistent with a moderate to high risk of a cardiac
event within the next 2-5 years.
• Coronary artery calcium measurement can improve
risk prediction in conventional intermediate-risk
patients and such scanning should be considered in
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individuals at intermediate risk for a coronary event
(0.6%/year to 2.0%/year) for clinical-decision making
regarding refinement of risk stratification28 (recent
data suggest that in low to intermediate risk patients
the current goals of applying only conventional risk
stratification may not be adequate in defining true
risk for myocardial infarction, at least in individuals
at an average age of 50 years29).
• High coronary calcium scores (an Agatston score
>100 or any score above the 75th percentile for age
and sex) denotes advanced coronary atherosclerosis
and provides a rationale for intensified LDL-c
lowering therapy and assignment of coronary risk to
a "coronary disease risk-equivalency" status (i.e.
secondary prevention goals such as a target LDL-c
range <100 mg/dl).
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